Pediatric Population Scientist, Tenure Track - New Brunswick, United States - Rutgers University

Description

Posting Summary

Rutgers Cancer Institute of New Jersey invites candidates to apply for Assistant to Professor level tenure-track faculty positions in pediatric population science, health outcomes, and disparities research. Academic rank is commensurate with qualifications and experience.

The successful behavioral or physician-scientist will join the Pediatric Population Science, Outcomes, and Disparities Research Section in the Division of Pediatric Hematology/Oncology, Department of Pediatrics.

The successful applicant will be expected to develop and maintain an innovative, independent, collaborative, and extramurally-funded research program.

Area of research interest is open, but we are particularly interested in applicants conducting research in pediatric hematology/oncology health disparities, health equity, cancer survivorship, psychosocial risk and resilience, or community-based research.

The Pediatric Hematology/Oncology Program provides comprehensive, state-of-the-art care for children and adolescents with cancer and blood disorders and is a member of the National Cancer Institute supported Children's Oncology Group (COG), the world's largest organization devoted exclusively to childhood and adolescent cancer research and clinical trials.

The LITE Program at Rutgers Cancer Institute of New Jersey provides long-term evaluation, support, and health education for the growing population of childhood cancer survivors.

The New Jersey Pediatric Hematology/Oncology Research Center of Excellence (NJ PHORCE) was established in 2021 is led by Dr.

Peter Cole, the Embrace Kids Endowed Chair and Professor of Pediatric Hematology and Oncology.

Its mission is to improve the lives of children diagnosed with cancer or blood disorders through research, training and education, community engagement, and public policy advocacy.

To highlight just a few examples, current members of the Center are at the forefront of their research fields:

in the biology of DNA repair; in the development of innovative targeted therapies; in preventing treatment-related toxicities; and in understanding disparities in treatment outcomes.

Visit us at .

NJ PHORCE is based in the Rutgers Cancer Institute, New Jersey's only NCI designated comprehensive cancer center.

We offer world-class quality cancer care providing the most advanced medicines and treatment options for patients in its New Brunswick facility as well as at its network of hospitals across the state through the partnership with the Robert Wood Johnson Barnabas Health System and University Hospital in Newark.

Rutgers Cancer Institute is the only NCI-designated comprehensive cancer center in the state and is easily accessible to New York City, Newark Airport, and Philadelphia by public transportation.

NJ PHORCE is dedicated to growing its research focused on health equity and outcomes among childhood cancer survivors.

Rutgers Cancer Institute has a vibrant and active research program in cancer prevention and control, cancer epidemiology and cancer disparities, and a Center for Tobacco Studies at RBHS.

There is a strong and growing research program in cancer survivorship in primary care settings at the Department of Family Medicine and Community Health at Rutgers Robert Wood Johnson Medical School.

With the integration of Rutgers Cancer Institute into the RWJBarnabas Health System, there are many opportunities for research collaboration and study implementation across New Jersey.

Program members also have strong ties with the diverse communities in New Jersey.

Rutgers Cancer Institute houses the SEER New Jersey State Cancer Registry, which facilitates research through high quality reporting of cancer cases across the state and rapid case ascertainment of new cancer cases.

In addition, Rutgers Cancer Institute has numerous shared resources available to faculty to facilitate research, including: 1) Population Science (DatStat, data collection); 2) Biostatistics; 3) a bio-specimen repository; and 4) precision oncology and access to ORIEN (Oncology Research Information Exchange Network), a shared resource for precision oncology data for epidemiology studies.

Rutgers Cancer Institute of New Jersey, the state's only NCI-designated Comprehensive Cancer Center located in New Brunswick, NJ, and RWJBarnabas Health, the state's largest health care delivery system, partner to deliver high-quality and sophisticated oncology care to patients close to home.

This integrated cancer care model combines the strength of both entities, offering access to the most advanced diagnostic and treatment options for adult and pediatric cancer patients, including clinical trials, immunotherapy, proton therapy, precision medicine, CAR T-cell therapy and cardio-oncology.

Unique opportunities exist for collaborations between clinical and research programs, including clinical trials research, cancer chemoprevention, clinical and basic pharmacology, and Phase 1 clinical trials.

Visit .

Faculty will have the exciting opportunity to be involved in teaching activities for medical students and residents as well as targeted lectures in their area of expertise.

For questions on this position or to learn more about our available positions , please contact the Rutgers Cancer Institute Faculty Recruitment Office at .

Position Status Full Time Posting Number 23FA0915 Posting Open Date 08/01/2023 Posting Close Date Qualifications Minimum Education and Experience Candidates must possess a doctoral degree in medicine, psychology, public health, epidemiology, or a health-related profession with a strong publication record.

Preference will be given to applicants with an established and extramurally funded research program.

Certifications/Licenses Required Knowledge, Skills, and Abilities Equipment Utilized Physical Demands and Work Environment Overview RBHS New Jersey's premier academic health center, Rutgers Biomedical and Health Sciences (RBHS) takes an integrated approach to educating students, providing clinical care, and conducting research, all with the goal of improving human health.

Aligned with Rutgers University–New Brunswick and collaborating university wide, RBHS includes eight schools, a behavioral health network, and five centers and institutes that focus on cancer treatment and research, neuroscience, advanced biotechnology and medicine, environmental and occupational health, and health care policy and aging research.

Our renowned faculty are teachers, health researchers and providers, and scientists with unparalleled experience who advance medical innovation and provide patient care informed by the latest research findings.

We offer an outstanding education and training in medicine, dentistry, pharmacy, public health, nursing, biomedical research, and the full spectrum of allied health careers.

An important mission of RBHS is to promote the careers of faculty, staff, and learners. Through this community of healers, scientists, and scholars, Rutgers is equipped as never before to transform lives.

Rutgers Robert Wood Johnson Medical School As one of the nation's comprehensive medical schools, Rutgers Robert Wood Johnson Medical School (RWJMS) is dedicated to pursuing excellence in education, research, healthcare delivery, and the promotion of community health. In cooperation with Robert Wood Johnson University Hospital, the medical school's principal affiliate, they comprise New Jersey's premier academic medical center. In addition, RWJMS has 34 other hospital affiliates and ambulatory care sites throughout the region. RWJMS encompasses 20 basic science and clinical departments and hosts centers and institutes, described below. The medical school maintains undergraduate, graduate, and postgraduate educational programs for more than 1,500 students on its campuses in New Brunswick and Piscataway. It provides continuing education courses for healthcare professionals and community education programs. Previously an academic unit of the University of Medicine and Dentistry of New Jersey, RWJMS became part of Rutgers, The State University of New Jersey, as part of the New Jersey Medical and Health Sciences Education Restructuring Act, on July 1, 2013.
Rutgers Cancer Institute As New Jersey's only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey, in partnership with RWJBarnabas Health, is a leader in cancer research, treatment, prevention, and education. Rutgers Cancer Institute offers world-class cancer care, providing patients with the most advanced treatment options through an integrated cancer care network, including clinical trials, immunotherapy, precision medicine, complex surgical procedures, and sophisticated radiation therapy techniques. Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, are one of only two programs in the state to offer blood and marrow transplantations and CAR T-cell therapy. It also houses the state's only hospital-based proton therapy center. Rutgers Cancer Institute is a cornerstone of New Jersey's premier academic health center, Rutgers Biomedical and Health Sciences (RBHS).

Construction is currently underway for a new $750 million state-of-the-art Cancer Center adjacent to the current Rutgers Cancer Institute facility and Robert Wood Johnson University Hospital.

The 510,000 square foot Jack and Sheryl Morris Cancer Center will be the state's first free-standing cancer hospital. It will feature outpatient and inpatient clinical space—including 84 infusion bays, 74 exam rooms, and 96 inpatient beds.

This is in addition to state-of-the-art laboratories where critical scientific investigation will be amplified, enabling physician-scientists to translate findings directly to patients.

The Jack and Sheryl Morris Cancer Center will also have the capacity to offer wellness and education resources all in one location.

Learn more about this incredible facility at .

Rutgers Cancer Institute is home to nearly 250 internationally recognized physicians and researchers.

The long-standing relationship with their NCI Research Consortium Partner Princeton University was recently leveraged to establish the Ludwig Cancer Research Princeton Branch with several faculty as founding members and leaders of the Branch.

Their work on cancer metabolism, not only through the new Ludwig Branch but also through the Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute, will accelerate and translate laboratory discoveries into clinical treatments through more effective and efficiently designed clinical trials.

The Rutgers Cancer Institute's Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence is an institute at the intersection of oncologic immunology and metabolism that seeks to increase research that leads to new therapies for patients; develop cutting-edge facilities to test new interventions; and facilitate commercial and university collaborations.

This includes discovery and production of novel cell therapy constructs via an institutional good manufactory practices (GMP) facility. Learn more about this facility at .

Rutgers Cancer Institute is committed to retaining, recruiting, and developing outstanding faculty, staff, and students, including those traditionally underrepresented in medicine in faculty, staff, and student bodies.

It aspires to be an agent of progress in advancing equality and justice while improving healthcare access and reducing healthcare disparities.

Visit us .More information on our community .

Statement Rutgers Cancer Institute of New Jersey , the state's only NCI-designated Comprehensive Cancer Center and RWJBarnabas Health, the state's largest health care delivery system partner to deliver high-quality and sophisticated oncology care to patients close to home.

This integrated cancer care model combines the strength of both entities, offering access to the most advanced diagnostic and treatment options for adult and pediatric cancer patients, including clinical trials, immunotherapy, proton therapy, precision medicine, CAR T-cell therapy and cardio-oncology.

Through the above mentioned partnership and an academic appointment at Rutgers, The State University of New Jersey, unique opportunities exist for collaborations between clinical and research programs, including clinical trials research, cancer chemoprevention, clinical and basic pharmacology, and Phase 1 clinical trials.

Mission
To accelerate scientific discovery focused on understanding cancer, innovating cancer treatment, and improving cancer prevention; to provide outstanding, novel, and compassionate patient care; to provide evidence-based and culturally informed education to physicians, nurses, researchers, staff, and the community; and to achieve cancer health equity in our state through outreach to and engagement of our extraordinarily diverse communities

Vision

Through our science, our evidence-based actions, our openness, and our respect for those we serve, we will advance cancer-focused research worldwide and reduce the burden of cancer in our catchment area.

By engaging with and empowering our exceptionally diverse populations, and addressing their questions and fears, we will engender hope for cancer patients and their families and play a critical role in strengthening the fabric of our communities by gaining and protecting their trust and providing access to the outstanding oncology care each person deserves.

Core Values

Curiosity and Discovery : encouraging an environment of continuous inquiry, creativity, and innovation to generate new knowledge

Integrity : earning the trust of those we serve and each other through honesty, transparency, accountability, and continuous reflection

Collaboration :
approaching all opportunities with an understanding that together we are better and can achieve more; promoting and maintaining an environment of teamwork and shared knowledge

Cultivating Diversity :
making conscientious efforts in all we do to ensure that our leadership, scientists, clinicians, supporting staff, and trainees reflect the rich diversity of the state of New Jersey and the patient populations and communities we serve


Respect and Caring :
consistently demonstrating caring, compassion, and respect through our words and actions

Perseverance : maintaining an unwavering commitment to our mission; embracing change, overcoming obstacles, and creating and recreating the path to achieve our goals

Rutgers Cancer Institute Commitment to Diversity, Equity, and Inclusion It is our responsibility to every participant in the healthcare space to address the longstanding, systemic structures of racism that affect our faculty and staff from thriving in the advancement of science and patient care. We understand that our patients, faculty, and staff come from all over and carry unique cultures and norms that impact how they interpret the world, their experiences, and their relationships. We are committed to fostering a diverse and inclusive environment where people who seek cancer care and the workforce that provide cancer care, both directly and indirectly, feel represented, welcomed, included, and supported.